LASAACI 2020 Fall Symposia
This is a live virtual two-hour event with speakers covering the topics of treatment and prevention of asthma as well as approaches to working up primary immunodeficiency. The LASAACI faculty are experts in their field and will provide evidence-based, clinical topics that address major aspects of the physician's practice and will provide learners exposure to new content.
This activity has been planned and implemented in accordance with the accreditation requirements and policies of the Accreditation Council for Continuing Medical Education (ACCME) through the joint providership of the American College of Allergy, Asthma & Immunology (ACAAI) and the Los Angeles Society of Allergy, Asthma & Clinical Immunology, Inc. The American College of Allergy, Asthma, and Immunology (ACAAI) is accredited by the Accreditation Council for Continuing Medical Education (ACCME) to provide continuing medical education for physicians.
The American College of Allergy, Asthma & Immunology designates this live activity for a maximum of 2 AMA PRA Category 1 Credits™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.
The American College of Allergy, Asthma & Immunology (ACAAI) is a provider, approved by the California Board of Registered Nursing, Provider Number CEP17239, for 2 contact hours.
This activity is supported by educational grants from Astra Zeneca, CSL Behring, Grifols and Takeda.
Allied health professionals
Upon completion of this activity the participant should be able to:
- Follow a world-expert in primary immunodeficiencies on how she approaches the diagnosis and treatment of PIDD
- Recognize the different monoclonal antibody therapies for severe asthma and future agents in the drug pipeline
All identified conflicts of interest have been resolved.
Wanda Phipatanakul, MD, MS – Speaker
Consultant/consulting fees – Genentech, Novartis
Speaker/honorarium – Novartis, Regeneron
Clinical Trial Support/consulting fees – Circassia, Merck, ALK, Inc., GlaxoSmithKline
Advisory Board Member/consulting fees – Regeneron
Charlotte Cunningham-Rundles, MD, PhD - Speaker
Consultant/consulting fees – CSL Behring, Atara Biotherapeutics,
Advisory Board/consulting fees – Takeda/Shire, UCB Biosciences, Momenta, Pharming
Raffi Tachdjian, MD, MPH – Planner, Chair, Moderator
Speaker/honorarium – Sanofi Regeneron, GlaxoSmithKline, Takeda, CSL Behring, Pharming
Advisory Board Member/consulting fee – Sanofi Regeneron, Takeda, CSL Behring, Pharming
Rita Kachru, MD – Planner
Speaker/honorarium– Aimmune, Genentech
Marc Meth, MD – Planner
Advisory Board Member/consulting fee – Dermira, Sanofi Genzyme, Optinose
Consultant – Regeneron
Sonal Patel, MD – Planner
Speaker/honorarium – Sanofi/Regeneron
The following have no relevant financial relationships to disclose:
Karol Anderson – Planner
Sheila Bonilla, MD – Planner
Dean Chiang, MD – Planner
- 2.00 AMA PRA Category 1 Credit™
- 2.00 Attendance
- 2.00 CBRN